Jacob sits down with Insitro CEO Daphne Koller to discuss founding Coursera, where and how ML can drive the most impact in drug development, and if foundation models can transform core drug discovery work and edtech.
00:00 intro
00:59 Daphne’s journey
09:02 AI and biology discovery
10:42 insitro vs. traditional pharma
19:47 phenotyping patients
25:44 early mistakes
29:34 the future of data
35:16 partnering with larger pharma companies
38:00 impact of LLMs on biopharma
43:47 over-hyped/under-hyped
